Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aduro Biotech (NQ: ADRO )

14.60 USD UNCHANGED
Last Price Updated: 7:22 PM EDT, Oct 5, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Aduro Biotech

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Aduro Biotech Presents Preclinical Data for BION-1301, a First-in-Class Antibody Targeting Human APRIL, at the 2018 European Congress of Immunology
Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that preclinical data for its first-in-class anti-APRIL antibody BION-1301 was presented at the 5th European Congress of Immunology in Amsterdam, The... 
From GlobeNewswire News Releases
ADRO Crosses Above Key Moving Average Level
In trading on Friday, shares of Aduro Biotech Inc (ADRO) crossed above their 200 day moving average of $7.38, changing hands as high as $7.47 per share. Aduro Biotech Inc shares are currently trading... 
Tags Stocks
From Market News Video
Aduro Biotech to Present at the 20th Annual H.C. Wainwright Global Investment Conference
Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the 20th Annual H.C. Wainwright Global Investment... 
From GlobeNewswire News Releases
Recent Analysis Shows Clearwater Paper, Aduro Biotech, Comtech Telecommunications, Ferroglobe, Badger Meter, and Donnelley Financial Solutions Market Influences — Renewed Outlook, Key Drivers of Growt
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Clearwater Paper... 
From GlobeNewswire News Releases
Aduro Biotech Granted Composition of Matter Patent for Novel Human APRIL Binding Antibodies
Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that the United States Patent and Trademark Office has issued a new composition of matter patent related to altered APRIL-binding antibodies, further... 
From GlobeNewswire News Releases
Implied IEIH Analyst Target Price: $31
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Aduro Biotech Reports Second Quarter 2018 Financial Results
Aduro Biotech, Inc. (NASDAQ: ADRO) today reported financial results for the second quarter ended June 30, 2018. Net loss for the second quarter of 2018 was $24.4 million, or $0.31 per share, and for... 
From GlobeNewswire News Releases
Report: Developing Opportunities within Newfield Exploration, Heritage Insurance, AptarGroup, Alder BioPharmaceuticals, TrueCar, and Aduro Biotech — Future Expectations, Projections Moving into 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Newfield Exploration... 
From GlobeNewswire News Releases
Aduro Biotech (ADRO) Shares Cross Above 200 DMA
In trading on Monday, shares of Aduro Biotech Inc (ADRO) crossed above their 200 day moving average of $8.19, changing hands as high as $8.40 per share. Aduro Biotech Inc shares are currently trading... 
Tags Stocks
From Market News Video
Commit To Buy Aduro Biotech At $5, Earn 8.6% Annualized Using Options
Investors considering a purchase of Aduro Biotech Inc (ADRO) stock, but cautious about paying the going market price of $8.05/share, might benefit from considering selling puts among the alternative... 
Tags Stocks
From Market News Video
Aduro Biotech Announces Initiation of Phase 1b Clinical Trial in Non-Small Cell Lung Cancer under Janssen Strategic Partnership for ADU-214 in Combination with Nivolumab
Aduro Biotech, Inc. (NASDAQ:ADRO) today announced the recent initiation of a Phase 1b study of ADU-214 (JNJ-64041757) in combination with nivolumab for the treatment of advanced lung cancer. ADU-214 is... 
From GlobeNewswire News Releases
44 Biggest Movers From Yesterday
Gainers American Electric Technologies, Inc (NASDAQ: AETI) shares surged 126.35 percent to close at $1.675 on Monday after ... 
Tags CSS NVCR IMMU
From Benzinga
Possible Trend Reversal, Aduro Biotech In Down on Heavy Volume (ADRO)
Aduro Biotech In shares are trading on heavy volume today, having fallen 8.7% to $7.71. About 394,000 shares have been traded today, as compared to the 30-day average volume... 
From Comtex SmarTrend® News Briefs
Aduro Biotech In Crosses Below its 10-day MA (ADRO)
Today, shares of Aduro Biotech In (NASDAQ:ADRO) have fallen below their 10-day MA of $8.21 on a volume of 223K shares. This may provide short-term investors a chance for... 
From Comtex SmarTrend® News Briefs
Deals of the day-Mergers and acquisitions
May 31 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1030 GMT on Thursday: ** Italy's oil and gas major Eni is in the process of reducing its stakes in its... 
Tags companyNews
From Reuters: Company News
Aduro Biotech Breaks Above 200-Day Moving Average - Bullish for ADRO
In trading on Wednesday, shares of Aduro Biotech Inc (ADRO) crossed above their 200 day moving average of $8.53, changing hands as high as $8.75 per share. Aduro Biotech Inc shares are currently... 
Tags Stocks
From Market News Video
Detailed Research: Economic Perspectives on Churchill Downs, Nordic American Tankers, News Corporation, Aduro Biotech, MannKind, and Crane — What Drives Growth in Today's Competitive Landscape
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Churchill Downs,... 
From GlobeNewswire News Releases
Aduro Biotech to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the Bank of America Merrill Lynch 2018 Health Care... 
From GlobeNewswire News Releases
UPDATE 2-Indonesia sees coal output flat in 2019 amid equipment shortage
* Miners waiting up to 12 months for excavators - contractor (Adds industry comments) 
Tags companyNews
From Reuters: Company News
Aduro Biotech Reports First Quarter 2018 Financial Results
Aduro Biotech, Inc. (NASDAQ:ADRO) today reported financial results for the first quarter ended March 31, 2018. Net loss for the first quarter of 2018 was $21.5 million, or $0.28 per share, compared to... 
From GlobeNewswire News Releases
Aduro Biotech Presents Early Observations From its Personalized Neoantigen-based pLADD Therapy Clinical Study at European Neoantigen Summit
pLADD Therapy Found to Induce Both Innate and Adaptive Immunity 
From GlobeNewswire News Releases
24 Stocks Moving In Wednesday's Pre-Market Session
Gainers Vicor Corporation (NASDAQ: VICR) rose 19.7 percent to $35 in pre-market trading. Vicor posted Q1 earnings of $0.10 ... 
Tags ADRO ATOS BABY
From Benzinga
Aduro Biotech Highlights Preclinical Data for Three Programs Reported at the American Association for Cancer Research Annual Meeting
Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that data from three of the company’s programs were presented at the American Association for Cancer Research (AACR) this week. The poster... 
From GlobeNewswire News Releases
The Math Shows VHT Can Go To $182
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Aduro Biotech to Present at the H.C. Wainwright Annual Global Life Sciences Conference
Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the H.C. Wainwright Annual Global Life Sciences... 
From GlobeNewswire News Releases
Aduro Biotech In Shares Up 16.7% Since SmarTrend's Buy Recommendation (ADRO)
SmarTrend identified an Uptrend for Aduro Biotech In (NASDAQ:ADRO) on March 8th, 2018 at $7.65. In approximately 2 weeks, Aduro Biotech In has returned 16.67% as of today's recent... 
From Comtex SmarTrend® News Briefs
Bullish Moving Average Cross by Aduro Biotech In (ADRO)
Aduro Biotech In (NASDAQ:ADRO) crossed over its 10-day moving average of $9.09 on a volume of 115K shares. This may provide swing traders with an opportunity for a long... 
From Comtex SmarTrend® News Briefs
Aduro Biotech Announces Upcoming Data Presentations at the 2018 American Association for Cancer Research Annual Meeting
Preclinical Data Showcases Immuno-Oncology Agents ADU-S100 STING Agonist, BION-1301 and ADU-1604 Antibodies 
From GlobeNewswire News Releases
Aduro Biotech to Present at the 28th Annual Oppenheimer Healthcare Conference
Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the 28th Annual Oppenheimer Healthcare Conference in... 
From GlobeNewswire News Releases
Rio Tinto's last two coal mines set to attract bids over $2.5 bln
MELBOURNE/LONDON, March 9 (Reuters) - At least three bidders are expected to submit final offers for global miner Rio Tinto's Hail Creek and Kestrel coal mines in Australia, which could fetch up to... 
Tags companyNews
From Reuters: Company News
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.